Edward F. Jackson

Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

Victor A. Levin, Luc Bidaut, Ping Hou et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 722 citations

Medicine, Neurosurgery, Oncology +9

First Soluble M@C₆₀ Derivatives Provide Enhanced Access to Metallofullerenes and Permit in Vivo Evaluation of Gd@C₆₀[C(COOH)₂]₁₀ as a MRI Contrast Agent

Robert D. Bolskar, Angelo F. Benedetto, Lars O. Husebo et al. · Journal of the American Chemical Society · 2003 · 400 citations

Natural Sciences, Chemistry, Materials Science +13

Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study

Glenn Liu, Hope S. Rugo, George Wilding et al. · Journal of Clinical Oncology · 2005 · 260 citations

Medicine, Oncology, Pharmacology +15

Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors

Roy S. Herbst, David S. Hong, Linnea Chap et al. · Journal of Clinical Oncology · 2009 · 242 citations

Medicine, Oncology, Pharmacology +13

Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

John de Groot, Kathleen R. Lamborn, Susan M. Chang et al. · Journal of Clinical Oncology · 2011 · 223 citations · Full text

Medicine, Oncology, Pharmacology +17